Page last updated: 2024-10-23

azasetron and Hearing Loss, Sensorineural

azasetron has been researched along with Hearing Loss, Sensorineural in 1 studies

azasetron: a selective 5-HT3 receptor antagonist; structure given in first source;

Hearing Loss, Sensorineural: Hearing loss resulting from damage to the COCHLEA and the sensorineural elements which lie internally beyond the oval and round windows. These elements include the AUDITORY NERVE and its connections in the BRAINSTEM.

Research Excerpts

ExcerptRelevanceReference
"SENS-401 (R-azasetron besylate) is effective against severe acoustic trauma-induced hearing loss."3.91SENS-401 Effectively Reduces Severe Acoustic Trauma-Induced Hearing Loss in Male Rats With Twice Daily Administration Delayed up to 96 hours. ( Broussy, A; Dyhrfjeld-Johnsen, J; Petremann, M; Poli, S; Romanet, C; Van Ba, CT, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Petremann, M1
Romanet, C1
Broussy, A1
Van Ba, CT1
Poli, S1
Dyhrfjeld-Johnsen, J1

Other Studies

1 other study available for azasetron and Hearing Loss, Sensorineural

ArticleYear
SENS-401 Effectively Reduces Severe Acoustic Trauma-Induced Hearing Loss in Male Rats With Twice Daily Administration Delayed up to 96 hours.
    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 2019, Volume: 40, Issue:2

    Topics: Acoustic Stimulation; Animals; Bridged Bicyclo Compounds, Heterocyclic; Cisplatin; Evoked Potentials

2019